'Medicare For All' Bills Prompt Warning From Former US FDA Commissioner Gottlieb

In an address to the National Press Club on 10 May, former FDA Commissioner Scott Gottlieb pointed to some of the challenges that CMS would face in supplying coverage for new technology, should a "Medicare for All" bill be adopted by Congress and signed by the president. Medtech Insight analyzed provisions that could impact industry in some of the proposed bills, in a comparative chart.

FDA Commissioner Scott Gottlieb discussed reimbursement challenges for medical products at the National Press Club in Washington, DC, with its President Alison Fitzgerald Kodjak.
Former FDA Commissioner Scott Gottlieb discussed challenges with "Medicare For All" bills at the National Press Club with club president Alison Fitzgerald Kodjak • Source: Michael Cipriano

Former US FDA Commissioner Scott Gottlieb, now an American Enterprise Institute scholar, told reporters at a National Press Club luncheon on 10 May that the device industry has good reason to be highly skeptical of expanding Medicare – as some so-called "Medicare for All" bills would do – and changing private coverage.

“I think it could squelch innovation and medical progress,” said Gottlieb, who left the top post at the agency on...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Policy & Regulation

Whoops! FDA Says Company Marketed Unauthorized Device. The Company Says The FDA Is Wrong

 

A recent FDA warning letter claims a Boston firm that specializes in wearable technology marketed a blood pressure device without agency approval. The company rejects the assertion and says the agency is out of step with federal law.

With CMS Coverage Established, Medtronic Looks To Next Steps For Renal Denervation

 
• By 

US Medicare has proposed national coverage of renal denervation for patients with uncontrolled hypertension. The treatment is seeing other advances as well, with Medtronic piloting a longer catheter and a multi-organ approach and a blood test to identify the best candidates fresh on the

House Bill Calls For ‘Non-Flushable’ Label On Personal Wipes

 

The US House of Representatives passes legislation requiring manufacturers of non-flushable wet wipes to label products as ‘non-flushable," a move endorsed by the Personal Care Products Council.